Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

Stereotaxis (NYSE: STXS) to participate in the Piper Sandler 35th Annual Healthcare Conference. David Fischel, Chairman and CEO, will present on Stereotaxis’ business and technology during a Fireside Discussion on November 30, 2023, at 1:30 pm ET. He will also be available for one-on-one meetings. The company aims to share its differentiated technology, clinical value, and growth strategy with investors.

ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35^th Annual Healthcare Conference.

Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, November 30, 2023, at 1:30 pm ET. Mr. Fischel will be available for one-on-one meetings that same day.

“We appreciate the opportunity to again participate at the Piper Sandler conference. We look forward to sharing Stereotaxis’ differentiated technology, clinical value, and growth strategy with investors,” says Mr. Fischel.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Stereotaxis Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
investors@stereotaxis.com

FAQ

What conference is Stereotaxis participating in?

Stereotaxis is participating in the Piper Sandler 35th Annual Healthcare Conference.

Who will be presenting on Stereotaxis’ business and technology?

David Fischel, Chairman and CEO, will be presenting on Stereotaxis’ business and technology.

When will the presentation take place?

The presentation will take place on November 30, 2023, at 1:30 pm ET.

What does Stereotaxis aim to share with investors?

Stereotaxis aims to share its differentiated technology, clinical value, and growth strategy with investors.